Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
The goal is to help patients use GLP-1 therapy safely and effectively with medical supervision
For patients with type 2 diabetes, inadequate A1c reduction on one agent may prompt a switch to another with stronger glycemic effects
Start your journey today
It is administered weekly by subcutaneous injection, starting at 0.25 mg and increasing monthly to a maximum of 2.4 mg, to minimize the adverse effects on the GI system reported by 73% of patients [10]
SmitsMMTonneijckLMuskietMHAKramerMHHPouwelsPJWPieters-van den BosICet al
Some patients may also drink less water or eat less fiber because their appetite is reduced, which can make constipation more likely
)
US$ 29.55
:max_bytes(150000):strip_icc()/GettyImages-1393991964-5452e32871e7431493115521bb14ae22.jpg)
US$ 25.76
US$ 21.94
